A detailed history of Wellington Management Group LLP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Wellington Management Group LLP holds 136,741 shares of URGN stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,741
Holding current value
$2.17 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.81 - $19.33 $1.89 Million - $2.64 Million
136,741 New
136,741 $2.05 Million
Q4 2023

Feb 12, 2024

BUY
$10.87 - $15.93 $1.14 Million - $1.67 Million
104,600 New
104,600 $1.57 Million
Q3 2023

Nov 14, 2023

BUY
$8.84 - $22.64 $619,356 - $1.59 Million
70,063 New
70,063 $981,000
Q1 2022

May 16, 2022

SELL
$5.92 - $9.73 $1.41 Million - $2.32 Million
-238,008 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$9.03 - $19.13 $716,006 - $1.52 Million
-79,292 Reduced 24.99%
238,008 $2.26 Million
Q3 2021

Nov 15, 2021

SELL
$14.31 - $18.39 $15.3 Million - $19.7 Million
-1,072,325 Reduced 77.17%
317,300 $5.34 Million
Q2 2021

Aug 16, 2021

SELL
$15.2 - $20.94 $4.03 Million - $5.55 Million
-264,958 Reduced 16.01%
1,389,625 $21.2 Million
Q1 2021

May 17, 2021

SELL
$17.99 - $26.96 $3.35 Million - $5.02 Million
-186,054 Reduced 10.11%
1,654,583 $32.2 Million
Q4 2020

Feb 12, 2021

SELL
$17.54 - $25.43 $2.72 Million - $3.95 Million
-155,353 Reduced 7.78%
1,840,637 $33.2 Million
Q3 2020

Nov 16, 2020

SELL
$18.81 - $26.42 $105,373 - $148,004
-5,602 Reduced 0.28%
1,995,990 $38.5 Million
Q2 2020

Aug 14, 2020

BUY
$16.5 - $29.7 $15 Million - $26.9 Million
906,207 Added 82.73%
2,001,592 $52.3 Million
Q1 2020

May 14, 2020

SELL
$13.68 - $34.6 $1.72 Million - $4.36 Million
-126,012 Reduced 10.32%
1,095,385 $19.5 Million
Q4 2019

Feb 11, 2020

BUY
$21.11 - $34.86 $25.8 Million - $42.6 Million
1,221,397 New
1,221,397 $40.8 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $361M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.